“ASSESSMENT OF CARDIOVASCULAR AND RENAL OUTCOMES FOLLOWING DAPAGLIFLOZIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE”. Asian Journal of Medical Research and Health Sciences, vol. 4, no. 2, June 2026, pp. 1398-03, https://doi.org/10.65605/a-jmrhs.2026.v04.i02.pp1398-1403.